Breast Implants Lymphoma Cancer
In a rush? You can use our Quick Contact Form to tell us the basic information about your case.
The Law Offices of Thomas J. Lamb represents people who have been harmed by unsafe medical products, including cases involving breast implants associated with lymphoma.
In more detail, the US Food and Drug Administration (FDA) has received reports about women who have had breast implant procedures done and, later, were diagnosed with these medical conditions:
- Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)
- Anaplastic Large Cell Lymphoma (ALCL)
- Non-Hodgkin Lymphoma (also known as Non-Hodgkin’s Lymphoma, NHL, or just Lymphoma)
- T-cell Lymphoma
We encourage you to submit a Breast Implants Cancer Case Review – it is free, confidential, and there is no obligation. Or, if you prefer, call our toll-free number, (800) 426-9535, to speak directly to attorney Tom Lamb about a possible breast implants case. Either way, you will get Mr. Lamb’s impressions — not an intake person, a paralegal, nor some other lawyer — about your case based on his many years of experience.
- Summary of Information
- The Disease
- FDA Information
- Frequently Asked Questions
➤ About the Disease
➤ Risk Factors
We are here to help the women and families who have experienced this unfortunate situation. We have successfully handled personal injury and wrongful death cases for people throughout the country.
Our firm does not put its clients into large class actions lawsuits. Rather, an individual lawsuit is filed for each case. There are no costs associated with having us review your possible breast implants case.
Be assured that the information you provide to our law firm is treated as strictly confidential. Submitting a case evaluation does not obligate you to hire our law firm.
Lastly, we want you to know that you will get a reply directly from attorney Tom Lamb no later than the next business day.
Most Recent Article on This Topic
Implants in Australia
Back in July, health officials in Australia recommended the ban of textured implants. Our previous July 2019 article, “Textured Breast Implants Ban: Onto Australia“, discussed the type of implants up for suspension by Australia’s Therapeutic Goods Administration (TGA).
Now in Australia, textured breast implants being sold there are under regulation due to the risk of BIA-ALCL. This recall and ban includes eight types of “macro” and “micro” textured implants. The Medtechdive article, “Australia enforces new regs on all breast implant makers, suspends some devices“, discusses what led to the regulations:
The regulator’s review took into account input from manufacturers, patients and the Breast Implant Working Group, a cohort of experts TGA convened in April after regulators in France and Canada took action against textured implants. The review involved lab testing of implant samples as well as a “full statistical review” of all BIA-ALCL cases reported through the end of May.
The TGA said all implants and tissue expanders will be banned for the next 6 weeks until concerns are addressed and fixed.
To read more of this article, click below:
Regulations and Statistics
Here are the regulations being placed on breast implant manufacturers and sponsors:
Implant sponsors must report all cases of BIA-ALCL to the TGA within 10 working days and provide six-monthly reports of Australian and worldwide supply, complaints and adverse events data.
Manufacturers must also provide doctors and patients with clear, written information about the risk of BIA-ALCL, which is very rare.
According to the Sydney Morning Herald article,” ‘Significant jump’ in cancer linked to breast implants as ban decision looms“, 73.9 percent of the 700 confirmed cases of BIA-ALCL were in connection with the highest textured implants, grade 4 and grade 3. Getting ALCL was 1 in 2800 for grade 4 implants and 1 in 3300 for grade 3 implants. Grade 2 implants were the least concerning, only being 19.6 percent of the 700 cases and with a risk of 1 in 84,000.[Read article in full at original source]
Our earlier articles about this breast implants lymphoma cancer situation:
- FDA Recalls Allergan Textured Implants
- Statistics Show An Increased Risk For BIA-ALCL With Textured Implants
- Textured Breast Implants Ban: Onto Australia
- FDA Fails When It Comes To Banning Textured Breast Implants
- Textured Breast Implants Bans on the Rise
- March 2019 FDA Meeting On Breast Implants: A Summary Of What You Need To Know
- Breast Implants FDA March 2019 Meeting: Lymphoma Cancer Was A Main Topic
- 2019 Discoveries and Warnings on Breast Implant-Associated Lymphoma
- Breast Implants Lymphoma Cancer Cases Update February 2019 – US & Canada
- Allergan Textured Breast Implants Recalled In Europe Due To BIA-ALCL
- FDA Provides Updated Number of Breast Implants Lymphoma Cancers
- New Data Released on Risk of Lymphoma Due to Breast Implants
- Breast Implant-Associated Lymphoma Diagnoses on the Rise
- What is the Risk of Death Due to Breast Implant-Associated Lymphoma?
- Treatments For Breast Implants Associated Lymphoma And Blood Cancer
- Breast Implants and Lymphoma: Who’s to Blame?
- Breast Implants Lymphoma Cancer: Diagnosis And Treatment Developments
- Breast Implant Lymphoma: Causes Uncertain, but Costs Undeniable
- March 2017 FDA Report: Breast Implants Linked To Lymphoma Blood Cancer
- Breast Implants Linked to Rare Lymphoma Blood Cancer